Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRolaCT: Surgery vs Dopamine Agonists for Prolactinoma
NCT04107480Phase 4Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2019
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in prolactinoma (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Health-Related Quality of Life at 12 months and Long-term remission at 36 months. Started Jun 2019; status: recruiting.
02
Conditions
prolactinoma
Beyond the preview
Go deeper on NCT04107480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04107480.